|
1
|
Slominski A, Kim TK, Brożyna AA,
Janjetovic Z, Brooks DL, Schwab LP, Skobowiat C, Jóźwicki W and
Seagroves TN: The role of melanogenesis in regulation of melanoma
behavior: Melanogenesis leads to stimulation of HIF-1α expression
and HIF-dependent attendant pathways. Arch Biochem Biophys.
563:79–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aebersold DM, Burri P, Beer KT, Laissue J,
Djonov V, Greiner RH and Semenza GL: Expression of
hypoxia-inducible factor-1alpha: A novel predictive and prognostic
parameter in the radiotherapy of oropharyngeal cancer. Cancer Res.
61:2911–2916. 2001.PubMed/NCBI
|
|
3
|
Koukourakis MI, Giatromanolaki A, Sivridis
E, Simopoulos C, Turley H, Talks K, Gatter KC and Harris AL:
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and
chemoradiotherapy outcome of squamous cell head-and-neck cancer.
Int J Radiat Oncol Biol Phys. 53:1192–1202. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mabjeesh NJ, Escuin D, LaVallee TM,
Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW
and Giannakakou P: 2ME2 inhibits tumor growth and angiogenesis by
disrupting microtubules and dysregulating HIF. Cancer Cell.
3:363–375. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maxwell PH, Pugh CW and Ratcliffe PJ: The
pVHL-hIF-1 system. A key mediator of oxygen homeostasis. Adv Exp
Med Biol. 502:365–376. 2001. View Article : Google Scholar
|
|
6
|
Zeng L, Zhou HY, Tang NN, Zhang WF, He GJ,
Hao B, Feng YD and Zhu H: Wortmannin influences hypoxia-inducible
factor-1 alpha expression and glycolysis in esophageal carcinoma
cells. World J Gastroenterol. 22:4868–4880. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen Y, Cao KE, Wang S, Chen J, He B, He
GU, Chen Y, Peng B and Zhou J: MicroRNA-138 suppresses
proliferation, invasion and glycolysis in malignant melanoma cells
by targeting HIF-1α. Exp Ther Med. 11:2513–2518. 2016.PubMed/NCBI
|
|
8
|
Kim JW, Tchernyshyov I, Semenza GL and
Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase
kinase: A metabolic switch required for cellular adaptation to
hypoxia. Cell Metab. 3:177–185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fujiwara S, Kawano Y, Yuki H, Okuno Y,
Nosaka K, Mitsuya H and Hata H: PDK1 inhibition is a novel
therapeutic target in multiple myeloma. Br J Cancer. 108:170–178.
2013.PubMed/NCBI
|
|
10
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg's contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Warburg O: On respiratory impairment in
cancer cells. Science. 124:269–270. 1956.PubMed/NCBI
|
|
13
|
Scott DA, Richardson AD, Filipp FV,
Knutzen CA, Chiang GG, Ronai ZA, Osterman AL and Smith JW:
Comparative metabolic flux profiling of melanoma cell lines: Beyond
the Warburg effect. J Biol Chem. 286:42626–42634. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bettum IJ, Gorad SS, Barkovskaya A,
Pettersen S, Moestue SA, Vasiliauskaite K, Tenstad E, Øyjord T,
Risa Ø, Nygaard V, et al: Metabolic reprogramming supports the
invasive phenotype in malignant melanoma. Cancer Lett. 366:71–83.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhatt AN, Chauhan A, Khanna S, Rai Y,
Singh S, Soni R, Kalra N and Dwarakanath BS: Transient elevation of
glycolysis confers radio-resistance by facilitating DNA repair in
cells. BMC Cancer. 15:3352015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhong J, Rajaram N, Brizel DM, Frees AE,
Ramanujam N, Batinic-Haberle I and Dewhirst MW: Radiation induces
aerobic glycolysis through reactive oxygen species. Radiother
Oncol. 106:390–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shimura T, Noma N, Sano Y, Ochiai Y,
Oikawa T, Fukumoto M and Kunugita N: AKT-mediated enhanced aerobic
glycolysis causes acquired radioresistance by human tumor cells.
Radiother Oncol. 112:302–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang C, Qin Y, Zhang H, Ma J and Yang K:
Upregulation of SLC19A2 in stem cell-like cancer cells of
nasopharyngeal carcinoma contributes to increased radioresistance
through enhanced glycolysis. Int J Radiat Oncol Biol Phys.
96:E5822016. View Article : Google Scholar
|
|
19
|
Jiang S, Wang R, Yan H, Jin L, Dou X and
Chen D: MicroRNA-21 modulates radiation resistance through
upregulation of hypoxia-inducible factor-1α-promoted glycolysis in
non-small cell lung cancer cells. Mol Med Rep. 13:4101–4107.
2016.PubMed/NCBI
|
|
20
|
Liu G, Li YI and Gao X: Overexpression of
microRNA-133b sensitizes non-small cell lung cancer cells to
irradiation through the inhibition of glycolysis. Oncol Lett.
11:2903–2908. 2016.PubMed/NCBI
|
|
21
|
Shen H, Hau E, Joshi S, Dilda PJ and
McDonald KL: Sensitization of glioblastoma cells to irradiation by
modulating the glucose metabolism. Mol Cancer Ther. 14:1794–1804.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo YM, Xia NX, Yang L, Li Z, Yang H, Yu
HJ, Liu Y, Lei H, Zhou FX, Xie CH, et al: CTC1 increases the
radioresistance of human melanoma cells by inhibiting telomere
shortening and apoptosis. Int J Mol Med. 33:1484–1490.
2014.PubMed/NCBI
|
|
23
|
Franken NA, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar
|
|
24
|
Rafehi H, Orlowski C, Georgiadis GT,
Ververis K, El-Osta A and Karagiannis TC: Clonogenic assay:
Adherent cells. J Vis Exp. 49:25732011.
|
|
25
|
Ning S, Shui C, Khan WB, Benson W, Lacey
DL and Knox SJ: Effects of keratinocyte growth factor on the
proliferation and radiation survival of human squamous cell
carcinoma cell lines in vitro and in vivo. Int J Radiat Oncol Biol
Phys. 40:177–187. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rao PN, Cessac JW, Tinley TL and Mooberry
SL: Synthesis and antimitotic activity of novel 2-methoxyestradiol
analogs. Steroids. 67:1079–1089. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu D and Kipps TJ: Reduction in
mitochondrial membrane potential is an early event in
Fas-independent CTL-mediated apoptosis. Cell Immunol. 195:43–52.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jenrette JM: Malignant melanoma: The role
of radiation therapy revisited. Semin Oncol. 23:759–762.
1996.PubMed/NCBI
|
|
29
|
Stevens G and McKay MJ: Dispelling the
myths surrounding radiotherapy for treatment of cutaneous melanoma.
Lancet Oncol. 7:575–583. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rofstad EK: Radiation biology of malignant
melanoma. Acta Radiol Oncol. 25:1–10. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Overgaard J, Overgaard M, Hansen PV and
von der Maase H: Some factors of importance in the radiation
treatment of malignant melanoma. Radiother Oncol. 5:183–192. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Masoud GN and Li W: HIF-1α pathway: Role,
regulation and intervention for cancer therapy. Acta Pharm Sin B.
5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pribluda VS, Gubish ER Jr, Lavallee TM,
Treston A, Swartz GM and Green SJ: 2-Methoxyestradiol: An
endogenous antiangiogenic and antiproliferative drug candidate.
Cancer Metastasis Rev. 19:173–179. 2000. View Article : Google Scholar
|
|
34
|
James J, Murry DJ, Treston AM, Storniolo
AM, Sledge GW, Sidor C and Miller KD: Phase I safety,
pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol
alone or in combination with docetaxel in patients with locally
recurrent or metastatic breast cancer. Invest New Drugs. 25:41–48.
2007. View Article : Google Scholar
|
|
35
|
Bruce JY, Eickhoff J, Pili R, Logan T,
Carducci M, Arnott J, Treston A, Wilding G and Liu G: A phase II
study of 2-methoxyestradiol nanocrystal colloidal dispersion alone
and in combination with sunitinib malate in patients with
metastatic renal cell carcinoma progressing on sunitinib malate.
Invest New Drugs. 30:794–802. 2012. View Article : Google Scholar
|
|
36
|
Sweeney C, Liu G, Yiannoutsos C, Kolesar
J, Horvath D, Staab MJ, Fife K, Armstrong V, Treston A, Sidor C, et
al: A phase II multicenter, randomized, double-blind, safety trial
assessing the pharmacokinetics, pharmacodynamics, and efficacy of
oral 2-methoxyestradiol capsules in hormone-refractory prostate
cancer. Clin Cancer Res. 11:6625–6633. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiao X, Huang X, Ye F, Chen B, Song C, Wen
J, Zhang Z, Zheng G, Tang H and Xie X: The miR-34a-LDHA axis
regulates glucose metabolism and tumor growth in breast cancer. Sci
Rep. 6:217352016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao D, Zou SW, Liu Y, Zhou X, Mo Y, Wang
P, Xu YH, Dong B, Xiong Y, Lei QY, et al: Lysine-5 acetylation
negatively regulates lactate dehydrogenase A and is decreased in
pancreatic cancer. Cancer Cell. 23:464–476. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shi M, Cui J, Du J, Wei D, Jia Z, Zhang J,
Zhu Z, Gao Y and Xie K: A novel KLF4/LDHA signaling pathway
regulates aerobic glycolysis in and progression of pancreatic
cancer. Clin Cancer Res. 20:4370–4380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shibuya K, Okada M, Suzuki S, Seino M,
Seino S, Takeda H and Kitanaka C: Targeting the facilitative
glucose transporter GLUT1 inhibits the self-renewal and
tumor-initiating capacity of cancer stem cells. Oncotarget.
6:651–661. 2015. View Article : Google Scholar :
|
|
41
|
Hoeijmakers JH: Genome maintenance
mechanisms for preventing cancer. Nature. 411:366–374. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lips J and Kaina B: DNA double-strand
breaks trigger apoptosis in p53-deficient fibroblasts.
Carcinogenesis. 22:579–585. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fortini P, Ferretti C and Dogliotti E: The
response to DNA damage during differentiation: Pathways and
consequences. Mutat Res. 743–744:160–168. 2013. View Article : Google Scholar
|
|
44
|
Zou H, Zhao S, Zhang J, Lv G, Zhang X, Yu
H, Wang H and Wang L: Enhanced radiation-induced cytotoxic effect
by 2-ME in glioma cells is mediated by induction of cell cycle
arrest and DNA damage via activation of ATM pathways. Brain Res.
1185:231–238. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pierce AJ, Hu P, Han M, Ellis N and Jasin
M: Ku DNA end-binding protein modulates homologous repair of
double-strand breaks in mammalian cells. Genes Dev. 15:3237–3242.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Little JB, Hahn GM, Frindel E and Tubiana
M: Repair of potentially lethal radiation damage in vitro and in
vivo. Radiology. 106:689–694. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mueck AO and Seeger H: 2-Methoxyestradiol
- biology and mechanism of action. Steroids. 75:625–631. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Long F, Si L, Long X, Yang B, Wang X and
Zhang F: 2ME2 increase radiation-induced apoptosis of keloid
fibroblasts by targeting HIF-1α in vitro. Australas J Dermatol.
57:e32–e38. 2016. View Article : Google Scholar
|
|
49
|
Aquino-Gálvez A, González-Ávila G,
Delgado-Tello J, Castillejos-López M, Mendoza-Milla C, Zúñiga J,
Checa M, Maldonado-Martínez HA, Trinidad-López A, Cisneros J, et
al: Effects of 2-methoxyestradiol on apoptosis and HIF-1α and
HIF-2α expression in lung cancer cells under normoxia and hypoxia.
Oncol Rep. 35:577–583. 2016.
|
